Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul-Aug;16(4):479-482.
doi: 10.1097/ADM.0000000000000943. Epub 2021 Dec 23.

Barriers to Engagement in Opioid Use Disorder Treatment After Buprenorphine Induction

Scott A Simpson  1 , Melissa Hordes, Joshua Blum, Deborah Rinehart, Alia Al-Tayyib
Affiliations

Barriers to Engagement in Opioid Use Disorder Treatment After Buprenorphine Induction

Scott A Simpson et al. J Addict Med. 2022 Jul-Aug.

Abstract

Objectives: Expanded access to buprenorphine induction, including via emergency departments, increases the likelihood of treatment engagement for patients with opioid use disorder (OUD). However, longer-term retention among these patients remains a challenge. In this study, we aimed to identify barriers to engaging and retaining patients with OUD in care and additional services that might improve retention.

Methods: We surveyed counselors at an urban safety net addictions treatment clinic.

Results: Twenty-five of 27 (93%) eligible counselors responded. Counselors described patients who were homeless, had no prior treatment history, or lacked health insurance as hardest to retain in treatment. Housing assistance, residential treatment placement, regular access to a phone, and mental health services were thought to be most beneficial for improving retention. Respondents most often reported that screening for services should happen at intake, and almost all respondents agreed that "retention of patients receiving treatment for OUD would improve with a dedicated case manager and/or more coordinated case management services."

Conclusions: Engagement in OUD treatment would be improved with interventions to mitigate the significant social and psychiatric comorbidities of addiction. Community- and emergency department-initiated buprenorphine is a promising intervention whose full promise cannot be realized without interventions to improve treatment retention.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest.

Figures

FIGURE 1.
FIGURE 1.
Addiction counselors’ perceptions of services needed and provided for patients with opioid use disorder.
See this image and copyright information in PMC

References

    1. Substance Abuse and Mental Health Services Administration. HHS releases new buprenorphine practice guidelines, expanding access to treatment for opioid use disorder. April 27, 2021. Updated April 27, 2021. Available at:https://www.samhsa.gov/newsroom/press-announcements/202104270930. Accessed October 22, 2021.
    1. Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med. 2015;9(5): 358–367. - PMC - PubMed
    1. Cao SS, Dunham SI, Simpson SA. Prescribing buprenorphine for opioid use disorders in the ED: A review of best practices, barriers, and future directions. Open Access Emerg Med. 2020;12:261–274. - PMC - PubMed
    1. Substance Abuse and Mental Health Services Administration. Use of medication-assisted treatment in emergency departments. National Mental Health and Substance Use Policy Laboratory. 2021. Accessed May 17, 2021. https://store.samhsa.gov/sites/default/files/SAMHSA_Digital_Download/pep....
    1. D’Onofrio G, Chawarski MC, O’Connor PG, et al. Emergency department-initiated buprenorphine for opioid dependence with continuation in primary care: Outcomes during and after intervention. J Gen Intern Med. 2017;32(6):660–666. - PMC - PubMed

Publication types

MeSH terms